Cargando…
Downregulated expression levels of USP46 promote the resistance of ovarian cancer to cisplatin and are regulated by PUM2
Ovarian cancer (OC) is a major contributor to cancer-related mortality in women. Despite numerous drugs being available for the treatment and improving the prognosis of OC, resistance to clinical chemotherapy remains a major obstacle for the treatment of advanced OC. Therefore, determining how to re...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893694/ https://www.ncbi.nlm.nih.gov/pubmed/33576437 http://dx.doi.org/10.3892/mmr.2021.11902 |